Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral nystatin prophylaxis in critically ill ICU patients
2008-005832-34Phase 3Active
- Sponsor
- Policlinico di Bari
- Start
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of nystatin in candidiasis, sponsored by Policlinico di Bari. Primary endpoints: Development of fungal colonization during ICU stay and Course of the colonization index over time. Started Sep 2008; status: active.
02
Drugs
nystatin
03
Conditions
candidiasis
Beyond the preview
Go deeper on 2008-005832-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005832-34.